Literature DB >> 26967661

The measles outbreak in Bulgaria, 2009-2011: An epidemiological assessment and lessons learnt.

Mark Muscat1, Lili Marinova, Annette Mankertz, Nina Gatcheva, Zafira Mihneva, Sabine Santibanez, Angel Kunchev, Radosveta Filipova, Mira Kojouharova.   

Abstract

Measles re-emerged in a nationwide outbreak in Bulgaria from 2009 to 2011 despite reported high vaccination coverage at national level. This followed an eight-year period since the last indigenous cases of measles were detected. The Bulgarian National Centre of Infectious and Parasitic Diseases collated measles surveillance data for 2009-2011. We analysed data for age group, sex, ethnicity, diagnosis confirmation, vaccination, hospitalisation, disease complications, and death and describe the outbreak control measures taken. The outbreak started in April 2009 following an importation of measles virus and affected 24,364 persons, predominantly Roma. Most cases (73%) were among children < 15 years old. Vaccination status was available for 52% (n = 12,630) of cases. Of children 1-14 years old, 22% (n = 1,769) were unvaccinated and 70% (n = 5,518) had received one dose of a measles-containing vaccine. Twenty-four measles-related deaths were reported. The Roma ethnic group was particularly susceptible to measles. The magnitude of the outbreak resulted primarily from the accumulation of susceptible children over time. This outbreak serves as a reminder that both high vaccination coverage and closing of immunity gaps across all sections of the population are crucial to reach the goal of measles elimination.

Entities:  

Keywords:  disease elimination; measles; measles-mumps-rubella (MMR) vaccine; outbreak

Mesh:

Substances:

Year:  2016        PMID: 26967661     DOI: 10.2807/1560-7917.ES.2016.21.9.30152

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  16 in total

1.  The role of healthcare providers in HPV vaccination programs - A meeting report.

Authors:  Alex Vorsters; Paolo Bonanni; Helena C Maltezou; Joanne Yarwood; Noel T Brewer; F Xavier Bosch; Sharon Hanley; Ross Cameron; Eduardo L Franco; Marc Arbyn; Nubia Muñoz; Mira Kojouharova; Jade Pattyn; Marc Baay; Emilie Karafillakis; Pierre Van Damme
Journal:  Papillomavirus Res       Date:  2019-08-30

Review 2.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

3.  Community-wide measles outbreak in the Region of Madrid, Spain, 10 years after the implementation of the Elimination Plan, 2011-2012.

Authors:  L García Comas; M Ordobás Gavín; J C Sanz Moreno; B Ramos Blázquez; E Rodríguez Baena; E Córdoba Deorador; M García Barquero; E Gil Montalbán; A Arce Arnáez; I Rodero Garduño; D Barranco Ordóñez; J Astray Mochales
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

4.  Progress and challenges in measles and rubella elimination in the WHO European Region.

Authors:  Siddhartha Sankar Datta; Patrick Michael O'Connor; Dragan Jankovic; Mark Muscat; Myriam Corrine Ben Mamou; Simarjit Singh; Theodoros Kaloumenos; Susan Reef; Mark Papania; Robb Butler
Journal:  Vaccine       Date:  2017-06-23       Impact factor: 3.641

5.  Re-Emergence of Measles in the European Countries; Another Challenge in Hand: Highlight from Italy.

Authors:  Taha Hussein Musa; Tauseef Ahmad; Jin Hui; Pingmin Wei
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

6.  Ongoing measles outbreak in Greece related to the recent European-wide epidemic.

Authors:  T Georgakopoulou; E Horefti; A Vernardaki; V Pogka; K Gkolfinopoulou; E Triantafyllou; S Tsiodras; M Theodoridou; A Mentis; T Panagiotopoulos
Journal:  Epidemiol Infect       Date:  2018-08-08       Impact factor: 4.434

Review 7.  Evolving measles status and immunization policy development in six European countries.

Authors:  Ivo Vojtek; Heidi Larson; Stanley Plotkin; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2022-02-18       Impact factor: 4.526

8.  Preliminary findings indicate nosocomial transmission and Roma population as most affected group in ongoing measles B3 genotype outbreak in Bulgaria, March to August 2017.

Authors:  Anna Kurchatova; Stefka Krumova; Nadezhda Vladimirova; Lubomira Nikolaeva-Glomb; Asya Stoyanova; Todor Kantardjiev; Nina Gatcheva
Journal:  Euro Surveill       Date:  2017-09-07

9.  Measles outbreak after 12 years without endemic transmission, Portugal, February to May 2017.

Authors:  Francisco George; João Valente; Gonçalo F Augusto; Andreia J Silva; Natália Pereira; Teresa Fernandes; Paula Palminha; Bárbara A Aguiar; António Martins; Estêvão Santos; Paula Valente; Etelvina Calé; Ana Leça; Paulo J Nogueira
Journal:  Euro Surveill       Date:  2017-06-08

10.  Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.

Authors:  Alessandro Cassini; Edoardo Colzani; Alessandro Pini; Marie-Josee J Mangen; Dietrich Plass; Scott A McDonald; Guido Maringhini; Alies van Lier; Juanita A Haagsma; Arie H Havelaar; Piotr Kramarz; Mirjam E Kretzschmar
Journal:  Euro Surveill       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.